| Customization: | Available |
|---|---|
| CAS No.: | 17217-76-4 |
| Formula: | N/a |
|
Still deciding? Get samples of US$ 50/Piece
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Ferric Citrate is a medication used to control high levels of phosphorus in the blood for people with chronic kidney disease who are on dialysis. It is also used to treat iron-deficiency anemia in adults with chronic kidney disease who are not on dialysis. As a phosphate binder, it works by binding to phosphorus from food in the diet, preventing it from being absorbed into the bloodstream. For treating anemia, it replenishes iron stores, allowing the body to produce more red blood cells. It is typically taken in tablet form with food, three times a day, and should be swallowed whole without being split, chewed, or crushed to avoid staining the teeth and mouth.
Ferric Citrate is considered a dual-action therapy, as it has the ability to control serum phosphate levels and also provide an iron replacement therapy. It is an iron-based compound with unique chemical characteristics that differentiate it from other forms of ferric citrate and from other phosphate binder and iron supplement therapies. The API of Auryxia (the brand name of Ferric Citrate) has a defined molar ratio of ferric iron to citrate anions, which contributes to its solubility and absorption properties.
It is important to follow the prescription instructions carefully and to keep all medications out of the reach of children. In case of an accidental overdose, seek medical help immediately. Regular blood tests will be necessary to monitor the body's response to Ferric Citrate.
Ferric Citrate may cause side effects, including severe stomach problems, high blood potassium levels, diarrhea, constipation, dark-colored stools, nausea, vomiting, and stomach pain. If any of these symptoms are severe or do not go away, consult a healthcare provider.
){kind=link}